-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HjvC3ScGqA4CD9Amw9jA2SwLmpFHCTcursTTHFP+hpOSee8/XQ+JaL42fHc1etPb k+BKEc0UbTRFCUMQzXnEWQ== 0001179110-07-008518.txt : 20070427 0001179110-07-008518.hdr.sgml : 20070427 20070427100031 ACCESSION NUMBER: 0001179110-07-008518 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20070426 FILED AS OF DATE: 20070427 DATE AS OF CHANGE: 20070427 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABIOMED INC CENTRAL INDEX KEY: 0000815094 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042743260 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 22 CHERRY HILL DR CITY: DANVERS STATE: MA ZIP: 01923 BUSINESS PHONE: 9787775410 MAIL ADDRESS: STREET 1: 22 CHERRY HILL DRIVE CITY: DANVERS STATE: MA ZIP: 01923 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TERMEER HENRI A CENTRAL INDEX KEY: 0001021038 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09585 FILM NUMBER: 07793582 BUSINESS ADDRESS: STREET 1: C/O GENZYME CORP STREET 2: ONE KENDALL SQ CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6172527500 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml FORM 4 - X0202 4 2007-04-26 0 0000815094 ABIOMED INC ABMD 0001021038 TERMEER HENRI A C/O ABIOMED, INC. 22 CHERRY HILL DRIVE DANVERS MA 01923 1 0 0 0 Common Stock, $.01 par value 2007-04-26 4 M 0 25000 7.00 A 54551 D Common Stock, $.01 par value 2307692 I By Genzyme Corporation Stock Option (right to buy) 7.00 2007-04-26 4 M 0 25000 7.0 D 1998-06-30 2007-07-01 Common Stock 25000 0 D Stock Option (right to buy) 19.69 2001-08-09 2010-08-09 Common Stock 5000 5000 D Stock Option (right to buy) 18.40 2002-08-08 2011-08-08 Common Stock 5000 5000 D Stock Option (right to buy) 4.71 2003-08-06 2013-05-21 Common Stock 5000 5000 D Common Stock (right to buy) 5.15 2004-08-13 2013-08-13 Common Stock 5000 5000 D Stock Option (right to buy) 10.41 2005-08-11 2014-08-11 Common Stock 8000 8000 D Stock Option (right to buy) 10.06 2006-08-09 2015-08-10 Common Stock 8000 8000 D Stock Option (right to buy) 13.21 2007-08-08 2016-08-09 Common Stock 8000 8000 D Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under ABIOMED, Inc. 1989 Non-Qualified Stock Option Plan for Non-Employee Directors. This option becomes exercisable in annual 20% increments commencing on the date set forth in Table II, Column 6. This option becomes exercisable in full on the date set forth in Table II, Column 6. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for the purposes of Section 16 or for any other purposes. The reporting person is the Chief Executive Officer of Genzyme Corporation. Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under ABIOMED, Inc. 2000 Stock Incentive Plan. /s/ Carrie-Ann Powierza (by power of attorney) 2007-04-26 EX-24 2 ex24termeer.txt EX24TERMEER LIMITED POWER OF ATTORNEY The undersigned does hereby appoint each of Daniel J. Sutherby, Sheila M. Flaherty, Christina Montalbano and Carrie Ann Powierza, signing singly, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as a director or officer of ABIOMED, Inc. (the "Company"), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5 and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in- fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, this power of attorney has been executed as of the 9th day of August, 2006 and shall remain in full force and effect until withdrawn by the undersigned in writing. Signature: /s/ Henri A. Termeer Print Name: Henri A. Termeer - 2 - -----END PRIVACY-ENHANCED MESSAGE-----